Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis

(Healio Neurology) Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022. “Given the fact that this population has a different background, different culture and socioeconomic status, the outcomes aren’t necessarily going to be the same as those from high-income countries,” Hanalise V. Huff, MD, MPH, of the Harvard T.H. Chan School of Public Health, said.